2015
Transforming Growth Factor &bgr;1 and Extracellular Matrix Protease Expression in the Uterosacral Ligaments of Patients With and Without Pelvic Organ Prolapse
Leegant A, Zuckerwise LC, Downing K, Brouwer-Visser J, Zhu C, Cossio MJ, Strube F, Xie X, Banks E, Huang GS. Transforming Growth Factor &bgr;1 and Extracellular Matrix Protease Expression in the Uterosacral Ligaments of Patients With and Without Pelvic Organ Prolapse. Urogynecology 2015, 21: 53-58. PMID: 25185601, PMCID: PMC4344824, DOI: 10.1097/spv.0000000000000130.Peer-Reviewed Original ResearchConceptsPelvic organ prolapseTGF-β1 expressionMMP-9 expressionTGF-β1Uterosacral ligamentsMMP-9Vaginal hysterectomyOrgan prolapseSmooth muscleFibrous tissueGreater pelvic organ prolapseGrowth factor-β1 expressionInstitutional review board approvalMatrix metalloproteinase-9Review board approvalAge-related alterationsGrowth factor-β1Benign indicationsMetalloproteinase-9Clinical dataImmunohistochemical stainingBoard approvalTrichrome stainingFactor-β1Β1 expression
2004
Total laparoscopic hysterectomy for oncological indications with outcomes stratified by age
O'Hanlan KA, Huang GS, Lopez L, Garnier AC. Total laparoscopic hysterectomy for oncological indications with outcomes stratified by age. Gynecologic Oncology 2004, 95: 196-203. PMID: 15385132, DOI: 10.1016/j.ygyno.2004.07.023.Peer-Reviewed Original ResearchConceptsTotal laparoscopic hysterectomyBody mass indexOvarian carcinomaAdhesive bowel obstructionEarly ovarian carcinomaFamilial ovarian carcinomaMean blood lossOverall complication rateComplex pelvic massChi-square testUrologic complicationsBowel obstructionHospital stayComplication rateBlood lossCervical dysplasiaEndometrial neoplasiaLaparoscopic hysterectomyMass indexVaginal carcinomaPelvic massPreoperative diagnosisSurgical durationSurgical outcomesOncological indications